GlassScriptPhysician profile
Jane A Mcdonald
NPI 1760421283
$1,743.30
in general payments reported to CMS, 2019-2025
44 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $99.51 · 2021: $86.01 · 2022: $132 · 2023: $295 · 2024: $411 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $149.77 | 2019-2024 | Prolia, Evenity, Tavneos |
| Lilly USA, LLC | $121.34 | 2022-2025 | Mounjaro |
| Pfizer INC. | $102.33 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.74 | 2019-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $74.55 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.40 | 2021-2025 | |
| Exact Sciences Corporation | $68.34 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $67.41 | 2019-2025 | Farxiga, Fasenra, Breztri |
| Novartis Pharmaceuticals Corporation | $61.28 | 2019-2025 | |
| United Therapeutics Corporation | $60.33 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $57.43 | 2024-2025 | Acthar |
| Novo Nordisk INC | $43.24 | 2024-2025 | Ozempic, Rybelsus |
| Xeris Pharmaceuticals, INC. | $42.09 | 2023-2025 | Gvoke Hypopen |
| Kyowa Kirin, INC. | $40.54 | 2024-2025 | Crysvita |
| Astellas Pharma US INC | $35.90 | 2023-2024 | Veozah |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.